PETS vs CVS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 13, 2026

PETS

37.7
AI Score
VS
CVS Wins

CVS

63.1
AI Score

Investment Advisor Scores

PETS

38score
Recommendation
SELL

CVS

63score
Recommendation
BUY

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric PETS CVS Winner
Revenue 76.78M 189.89B CVS
Net Income -12.58M 4.89B CVS
Net Margin -16.4% 2.6% CVS
Operating Income -12.65M 8.95B CVS
ROE -74.6% 7.8% CVS
ROA -21.2% 2.2% CVS
Total Assets 59.40M 220.11B CVS
Cash 11.42M 5.19B CVS
Current Ratio 0.60 0.92 CVS
Free Cash Flow -9.97M 8.32B CVS

Relative Price Performance (Last 90 Days)

PETS 1M: -22.9% · 3M: -46.3% CVS 1M: -3.5% · 3M: -5.0%

Current Technical Phase

PETS

Markdown
Sell / avoid

Price below a falling SMA50 (slope -16.9%), weak momentum, RSI 21

RSI (14): 21.2 · Price: $0.94

CVS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 51

RSI (14): 51.0 · Price: $89.35

Fundamentals Snapshot

Metric PETS CVS
Market Cap — —
Forward P/E 13.4 10.3
Trailing P/E — 10.4
Revenue (TTM) — —
Revenue Growth -0.2% 0.1%
Gross Margin 0.3% 0.1%
Operating Margin -0.2% 0.0%
EPS -1.20 8.61
Dividend Yield — 0.03%

Frequently Asked Questions

Based on our detailed analysis, CVS is currently the stronger investment candidate, winning 10 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.